Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

High protein breakfasts help you feel fuller but do not change how much you eat later

A plant-based drink and an animal-based meal triggered similar satiety hormone responses and small appetite reductions after breakfast, yet neither changed how much participants ate at lunch, suggesting that increasing protein at breakfast may support satiety

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

A plant-based drink and an animal-based meal triggered similar satiety hormone responses and small appetite reductions after breakfast, yet neither changed how much participants ate at lunch, suggesting that increasing protein at breakfast may support satiety without automatically reducing total energy intake.

Study: The effect of consuming different dietary protein sources at breakfast upon self rated satiety, peptide YY, glucagon like peptide-1, and subsequent food intake in young and older adults. Image Credit: Muhammad Umair132 / Shutterstock

In a recent study published in the European Journal of Nutrition, researchers at Newcastle University, UK, investigated the impact of consuming different protein sources at breakfast on adults' subsequent hunger and food consumption, as well as the regulation of associated hormones.

Their findings indicate that high-protein breakfasts, both plant-based and animal-based, elicited stronger satiety hormone responses and appetite suppression, which was significant for the plant-based drink and trending for the animal-based meal. However, neither influenced the total energy consumed during the afternoon meal.

Sustainability and Protein Source Implications for Appetite

Adequate protein intake is vital for health, but environmental and ethical concerns are driving interest in sustainable, plant-based alternatives.

The Food and Agriculture Organization promotes alternative proteins as part of its global sustainability goals, leading to growth in plant-based foods and drinks.

Protein source can influence digestive, metabolic, and appetite responses, as amino acids stimulate satiety hormones such as peptide tyrosine tyrosine (PYY) and glucagon-like peptide 1 (GLP-1) while suppressing ghrelin.

Studies comparing protein types have yielded inconsistent results; some find that casein or pea proteins are more satiating than soy, while others report stronger effects for whey.

Plant- and animal-based meals may also differ in their ability to trigger gut hormone release, with outcomes varying by population and protein form. Liquids typically reduce appetite less than solid foods, though this difference in relation to protein source remains unclear.

In the UK, most adults meet their protein recommendations, but older adults may require more due to a reduced appetite and an increased risk of muscle loss. Since breakfast tends to be low in protein, it offers an opportunity to enhance intake.

This study aimed to compare the effects of plant-based and animal-based high-protein breakfasts with a low-protein control on appetite, satiety hormones, and energy intake in younger and older adults.

Controlled Crossover Design for Breakfast Interventions

Researchers employed a randomized, within-subject, crossover design, in which 18 healthy adults, comprising 12 between 18 and 35 years old and 6 over 65, participated in three breakfast conditions: a plant-based, high-protein drink, an animal-based, high-protein breakfast, and a low-protein, high-carbohydrate breakfast.

Each meal was energy-matched, with the high-protein treatments containing 30 g of protein. However, the plant-based drink contained more fiber at 7.8 g than the animal-based meal at 4.5 g. Participants attended the laboratory in a fasted state after consuming a standardized evening meal and avoiding caffeine, alcohol, and exercise.

Schematic of study protocol

Appetite Measurements and Hormone Sampling Procedures

Appetite was measured using visual analogue scales at baseline and at regular intervals for four hours after breakfast, while blood samples were collected at specific time points to measure plasma PYY and GLP-1 concentrations. After the final blood draw, participants consumed an ad libitum pasta lunch to assess energy intake.

Statistical analyses employed mixed models to evaluate the effects of treatment, time, and age group, while controlling for baseline values. Pairwise comparisons with Bonferroni correction were applied where significant effects were found. Associations between appetite, hormone levels, and energy intake were examined using repeated measures correlation analysis.

Hormonal and Appetite Responses to Protein Type

Both plant-based and animal-based high-protein breakfasts produced stronger satiety hormone responses than the low-protein, high-carbohydrate meal.

GLP-1 levels were significantly higher after both high-protein meals compared with the control, with no difference between the two protein types. Similar patterns were observed for PYY, which increased significantly after the high protein meals compared with the control, again showing no difference between protein sources.

Subjective appetite ratings were significantly lower following the plant-based protein drink and showed a trend toward reduction after the animal-based meal compared with the low-protein meal. However, these differences were modest and mostly below the 15 mm threshold considered necessary to influence eating behavior meaningfully. Energy intake at the ad libitum lunch did not differ between treatments, and no age-related effects were observed.

Correlation analyses showed that subjective appetite was positively associated with subsequent energy intake. Unexpectedly, GLP-1 and PYY levels showed weak, positive associations with energy intake; however, this represented only a statistical trend, with p values of 0.074 and 0.078, respectively, and was not significant at the 0.05 level.

Within participants, no associations were found between changes in hormone levels, appetite, or energy intake. Overall, both high-protein breakfasts promoted greater satiety hormone responses and appetite suppression than the low-protein meal, but did not affect later food intake.

Comparing Plant-Based and Animal-Based Satiety Effects

This study found that plant- and animal-based high-protein breakfasts similarly enhanced satiety hormones GLP-1 and PYY, and reduced appetite, compared with a high-carbohydrate, low-protein meal, with no difference observed between protein sources or age groups.

Although the plant-based drink appeared to produce slightly quicker hormonal responses, a tentative observation the authors suggested might be due to faster gastric emptying of liquids, these effects did not translate into reduced energy intake at lunch.

The comparable responses indicate that plant-based proteins can effectively replace animal proteins in supporting satiety without affecting subsequent calorie intake. Strengths of this analysis include a controlled, crossover design and inclusion of older adults.

Limitations include the small size of the older adult subgroup and the absence of solid plant-based and liquid animal-based conditions, which limit the ability to isolate the effects of protein form and source. Moreover, the study was not statistically powered to detect age differences, which increases the risk of overlooking true age-related effects.

Implications for Sustainable and Practical Breakfast Protein Strategies

In conclusion, a plant-based, high-protein drink appears to be a practical and sustainable alternative for increasing protein intake without affecting later eating behavior. However, future studies are needed to assess the long-term acceptability of these dietary interventions and the real-world applications of these findings.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What proteins does the body tolerate?

The study began with a bowl of mouse chow. Rather than start piecewise, one food after another, the researchers screened regulatory T cells from mice given a normal diet. They looked for what the regulatory T cells were attaching to, then mapped them backward to specific parts of the chow. They found three proteins-more specifically, they found small, specific bits of those proteins called epitopes-that the regulatory T cells recognized. The epitopes were found in three different food proteins: one from corn, one from wheat, and one from soybean. Notably, all three epitopes are from seed proteins, suggesting that these highly abundant plant proteins are commonly recognized by the immune system's tolerance mechanisms. Furthermore, the most abundant T cells were those reactive to the corn epitope, which makes sense given that corn is not a common allergy. Soy, on the other hand, is one of the major allergies in humans, so the identification of a soybean epitope is especially exciting, notes Blum. Additionally, the mammalian receptor that interacts with the identified soybean epitope also interacts with sesame, helping explain cross-tolerance, or when a tolerance to one food infers a tolerance to another. With the new epitopes identified, the researchers had a few follow-up questions, like where do these regulatory T cells live? And how do they perform in an inflamed versus a healthy environment? They used mice and cell culture models to answer these questions, finding that the regulatory T cells are primarily located in the gut and their activities vary based on whether they are in an inflamed or healthy environment, either working to reduce inflammation or sustain an absence of inflammation.

Source: www.news-medical.net ↗
02Collaboration has played a significant role in your research career. Can you highlight some of the most impactful collaborations you've had and how they have contributed to your research in axon biology?

A significant collaboration is with the Versus Arthritis Pain Center in Nottingham, in particular with Vicky Chapman and Gareth Hathway. Initially, my work wasn't focused on pain research, but joining forces with experts from this center led half of my lab's work to be directed towards pain-related projects. Another meaningful collaboration involves studying motor neuron diseases alongside Prof. Rob Layfield and Dr. Dan Scott. This collaboration allows us to leverage our expertise in RNA and neuron development and apply it to conditions like motor neuron disease.

Source: www.news-medical.net ↗
03How does COTI-2 compare to other p53 restoration drug candidates in development?

COTI-2 has an effect on mutated p53 protein that is similar to that documented for a few other members of the same class of compounds. COTI-2 is a third generation thiosemicarbazone specifically engineered for low toxicity. Other drugs in development target the mdm2 protein leading to increased functional p53 by decreasing the destruction of normal p53 protein. COTI-2 also has a unique effect on the PI3K/AKT pathway via a direct gene level up regulation of a specific protein (PIK3IP) that is known to inhibit PI3K. This means that COTI-2 is potentially effective in cancers with p53 mutations as well as in mutations of the PI3K/AKT pathway. This effect has been confirmed in an animal model of human ovarian cancer.

Source: www.news-medical.net ↗
04This year has been a little bit different and we have had to do a lot of these interviews virtually. Why do you think events like Pittcon are more important now than ever?

It is one of the largest gathering of analytical and other scientists, and yet, all the presentations are in a relatively localized area, so one can easily access a greater variety of topics and scientists in a limited amount of time. It is also one of the biggest exhibitions in the world, and having this exhibition can provide useful technical information, often unknown or unexplained in academic talks. I bring a significant number of students to Pittcon. They must give a talk or poster in order to attend. I think this is really important as it is good for them. They love the whole experience, from the networking, giving their presentations, being exposed to new topics, new parts of the country. A lot of them have not traveled so it is a wonderful opportunity. That is why we always bring as many students as we can and have them participate; they love it.

Source: www.news-medical.net ↗
05How does vitamin D strengthen the immune system?

More specifically, the study showed that the female patient produced very few cathelicidins, which is a natural toxin found in the immune cells of the lungs needed to fight tuberculosis. In most people infected by tuberculosis, tuberculosis bacteria attack the immune cells of the lungs. The immune cells fight the bacteria by eating them. But the tuberculosis bacterium has developed various evasive mechanisms that reduce the immune cells’ ability to digest and thus to kill the Mtb. “You could say that the tuberculosis bacterium has developed a way to lull the immune cells to sleep. This enables the disease the hide inside the immune cells, making it invisible to other parts of the immune system,” Martin Kongsbak-Wismann explains. This is where vitamin D enters the picture. Because vitamin D is able to counteract the soporific effect of the tuberculosis bacteria by making the immune cells produce more of the cathelicidin toxin. “Cathelicidin is like a microscopic needle that is able to pierce the tuberculosis bacteria. And when it does, it weakens the bacteria’s soporific effect on the immune cells. This restores the immune cells’ ability to kill tuberculosis bacteria,” says Martin Kongsbak-Wismann and adds: “We were amazed by the effect of vitamin D. In immune cells from healthy control subjects, vitamin D improved the cells’ ability to fight Mtb, whereas in the female patient’s immune cells we saw no response to vitamin D. This shows that vitamin D is key to the immune system’s ability to fight Mtb and prevent tuberculosis.” Al-Jaberi, F.A.H., et al. (2022) Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report. Frontiers in Immunology. doi.org/10.3389/fimmu.2022.1038960.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →